Articles
29.08.2018
Brexit pharmaceutical market access and the UK

With eight months left before the UK leaves the EU in March 2019, it was hoped that a clear strategy...

Read more
Publications
22.08.2018
Biosimilar market access considerations

Purpose of this study was to understand the EU member state' local market access needs in relation t...

Read more
Articles
17.08.2018
Biosimilars Price Controls

The government has launched a consultation that outlines the proposed changes to its price controls ...

Read more
Articles
25.07.2018
EU-wide HTA clinical assessment

The European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health...

Read more
News
16.07.2018
NICE's STA appraisal process changes

In June 2018, Remap Consulting had the pleasure of attending the annual National Institute of Health...

Read more
Articles
07.06.2018
Addressing antimicrobial resistance (AMR)

At the current rate, annual deaths due to AMR is expected to reach 10 million by 2050 globally, with...

Read more
Publications
23.05.2018
Reducing drug wastage

The aim of this study was to determine the impact of delivery device reducing drug wastage.

Read more
Case Studies
21.05.2018
PMA launch submission across the EU

Development and implementation of the optimum price submission strategy for a product in the EU.

Read more
Publications
11.05.2018
ICERs are not all the same

To determine if there is a difference between incremental cost-effectiveness ratios (ICERs) in oncol...

Read more
Articles
27.04.2018
Indication based pricing

In the current climate of tighter budgetary controls and greater price scrutiny, a uniform pricing s...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.